Skip to main content

Table 2 VL-decrease [log copies/ml] at week 4, 12, 24 and 48 after initiation of antiretroviral therapy with respect to the MDR1 2677 and 3435 genotypes. Statistical analysis was done with the Kruskall-Wallis test.

From: No influence of the P-glycoprotein polymorphisms MDR1 G2677T/A and C3435T on the virological and immunological response in treatment naïve HIV-positive patients

  

week 4

week 12

week 24

week 48

MDR1

n =

median [log/ml]

mean [log/ml]

SA

p =

n =

median [log/ml]

mean [log/ml]

SA

p =

n =

median [log/ml]

mean [log/ml]

SA

p =

n =

median [log/ml]

mean [log/ml]

SA

p =

2677

GG

22

-2,301

-2,210

0,590

>0.3

22

-3,048

-3,287

0,682

>0.05

20

-3,943

-3,876

0,748

>0.9

15

-3,716

-3,835

0,777

>0.5

 

GT

21

-2,602

-2,537

0,566

 

19

-3,786

-3,794

0,635

 

17

-3,929

-3,933

0,499

 

16

-3,942

-3,946

0,488

 
 

TT

17

-2,495

-2,372

0,651

 

16

-3,739

-3,602

0,595

 

17

-4,000

-3,850

0,708

 

14

-3,977

-3,795

0,615

 
 

AG

3

-2,301

-2,689

0,606

§

4

-3,952

-4,167

0,884

§

4

-4,500

-4,537

0,702

§

4

-4,151

-4,362

0,726

§

 

AT

3

-1,875

-2,032

0,493

§

3

-4,176

-3,752

0,690

§

3

-4,176

-4,085

0,223

§

3

-4,176

-4,085

0,223

§

3435

CC

17

-2,301

-2,382

0,501

>0.6

19

-3,301

-3,416

0,699

>0.4

17

-4,000

-3,974

0,685

>0.7

13

-3,716

-3,818

0,709

>0.6

 

CT

32

-2,247

-2,363

0,640

 

29

-3,778

-3,742

0,737

 

28

-3,812

-3,830

0,704

 

25

-3,929

-3,984

0,614

 
 

TT

17

-2,398

-2,348

0,668

 

17

-3,602

-3,530

0,595

 

17

-4,176

-4,054

0,571

 

15

-4,114

-3,849

0,609

 

2677/3435

H1

15

-2,398

-2,398

0,531

>0.8

16

-3,199

-3,361

0,724

>0.08

14

-3,943

-3,926

0,715

>0.8

10

-3,659

-3,774

0,787

>0.4

 

H2

38

-2,548

-2,463

0,611

 

35

-3,778

-3,706

0,624

 

34

-3,954

-3,891

0,614

 

30

-3,954

-3,875

0,556

 
 

H3

7

-1,778

-1,806

0,502

§

6

-2,827

-3,089

0,506

§

6

-3,827

-3,761

0,807

§

5

-4,176

-3,958

0,741

§

 

H5

6

-2,261

-2,361

0,642

§

7

-4,176

-3,989

0,833

§

7

-4,301

-4,343

0,594

§

7

-4,176

-4,243

0,584

§

total

 

66

    

64

    

61

    

52

    
  1. composite genotypes: see methods; §excluded from statistical analysis